Skip to main content
Erschienen in: Journal of Neurology 11/2015

01.11.2015 | Original Communication

Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson’s disease and multiple system atrophy in a Chinese population

verfasst von: YongPing Chen, Bei Cao, Jing Yang, QianQian Wei, Ru Wei Ou, Bi Zhao, Wei Song, XiaoYan Guo, HuiFang Shang

Erschienen in: Journal of Neurology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Whether polymorphisms rs11856808 and rs9652490 of the Leucine-rich repeat and Ig domain containing, Nogo receptor-interacting protein-1 (LINGO1) gene, as well as rs10968280, rs13362909 and rs7033345 of the LINGO2 gene, increase the risk for Parkinson’s disease (PD) is controversial. Considering the overlap of the clinical and pathological characteristics among PD and multiple system atrophy (MSA), we explored the associations between these five polymorphisms and PD and MSA in a Chinese population. A total of 1055 PD patients, 320 MSA patients, and 810 healthy controls (HCs) were genotyped for these five polymorphisms in LINGO1 and LINGO 2 using Sequenom iPLEX Assay technology. Moreover, after combining our results with available published data, a meta-analysis was conducted to investigate the associations between LINGO 1 rs11856808 and rs9652490 and the risk of PD. The frequency of the minor alleles “T” of LINGO1 rs11856808 was significantly lower in PD than that in HCs (p = 0.011, OR 0.89, 95 % CI 0.81–0.97), but not in MSA. Moreover, there were no significant differences in the minor allele frequency distributions of the other four polymorphisms between PD and HCs, and between MSA and HCs. The meta-analysis showed a lack of association of rs9652490 and PD, regardless of the genetic model or ethnic origin. However, the rs11856808 allele decreased the risk of PD in patients of Asian origin in a dominant genetic model. Our findings suggest that rs11856808 plays a protective role by decreasing the risk for PD, but not for MSA, in Asian population, the other four polymorphisms do not contribute to the risk for PD and MSA.
Literatur
1.
Zurück zum Zitat Agundez JA, Lorenzo-Betancor O, Pastor P, Garcia-Martin E, Luengo A, Alonso-Navarro H, Jimenez-Jimenez FJ (2012) LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson’s disease: results of a meta-analysis. Parkinsonism Relat Disord 18:657–659CrossRefPubMed Agundez JA, Lorenzo-Betancor O, Pastor P, Garcia-Martin E, Luengo A, Alonso-Navarro H, Jimenez-Jimenez FJ (2012) LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson’s disease: results of a meta-analysis. Parkinsonism Relat Disord 18:657–659CrossRefPubMed
2.
Zurück zum Zitat Annesi F, De Marco EV, Rocca FE, Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Tarantino P, De Mari M, Lamberti P, Gallerini S, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Torchia G, Zappia M, Annesi G, Quattrone A (2011) Association study between the LINGO1 gene and Parkinson’s disease in the Italian population. Parkinsonism Relat Disord 17:638–641CrossRefPubMed Annesi F, De Marco EV, Rocca FE, Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Tarantino P, De Mari M, Lamberti P, Gallerini S, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Torchia G, Zappia M, Annesi G, Quattrone A (2011) Association study between the LINGO1 gene and Parkinson’s disease in the Italian population. Parkinsonism Relat Disord 17:638–641CrossRefPubMed
3.
Zurück zum Zitat Bialecka M, Kurzawski M, Tan EK, Drozdzik M (2010) Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson’s disease in a Polish population, and a meta-analysis. Neurosci Lett 472:53–55CrossRefPubMed Bialecka M, Kurzawski M, Tan EK, Drozdzik M (2010) Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson’s disease in a Polish population, and a meta-analysis. Neurosci Lett 472:53–55CrossRefPubMed
4.
Zurück zum Zitat Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32(Suppl):S125–S127CrossRefPubMed Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32(Suppl):S125–S127CrossRefPubMed
5.
Zurück zum Zitat Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT (2011) Basic statistical analysis in genetic case–control studies. Nat Protoc 6:121–133PubMedCentralCrossRefPubMed Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT (2011) Basic statistical analysis in genetic case–control studies. Nat Protoc 6:121–133PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, Rajput A, Calon F (2014) Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord 29:1637–1647 Delay C, Tremblay C, Brochu E, Paris-Robidas S, Emond V, Rajput AH, Rajput A, Calon F (2014) Increased LINGO1 in the cerebellum of essential tremor patients. Mov Disord 29:1637–1647
7.
Zurück zum Zitat Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676PubMedCentralCrossRefPubMed Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Guo XY, Chen YP, Song W, Zhao B, Cao B, Wei QQ, Ou RW, Yang Y, Yuan LX, Shang HF (2014) SNCA variants rs2736990 and rs356220 as risk factors for Parkinson’s disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol Aging 35:2882.e2881–e2886 Guo XY, Chen YP, Song W, Zhao B, Cao B, Wei QQ, Ou RW, Yang Y, Yuan LX, Shang HF (2014) SNCA variants rs2736990 and rs356220 as risk factors for Parkinson’s disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol Aging 35:2882.e2881–e2886
9.
Zurück zum Zitat Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H (2011) LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett 487:174–176CrossRefPubMed Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H (2011) LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett 487:174–176CrossRefPubMed
10.
Zurück zum Zitat Haubenberger D, Hotzy C, Pirker W, Katzenschlager R, Brucke T, Zimprich F, Auff E, Zimprich A (2009) Role of LINGO1 polymorphisms in Parkinson’s disease. Mov Disord 24:2404–2407PubMedCentralPubMed Haubenberger D, Hotzy C, Pirker W, Katzenschlager R, Brucke T, Zimprich F, Auff E, Zimprich A (2009) Role of LINGO1 polymorphisms in Parkinson’s disease. Mov Disord 24:2404–2407PubMedCentralPubMed
11.
Zurück zum Zitat Homma S, Shimada T, Hikake T, Yaginuma H (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 9:1–26CrossRefPubMed Homma S, Shimada T, Hikake T, Yaginuma H (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns 9:1–26CrossRefPubMed
12.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models. Proc Natl Acad Sci USA 104:14430–14435PubMedCentralCrossRefPubMed Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson’s disease models. Proc Natl Acad Sci USA 104:14430–14435PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Klebe S, Thier S, Lorenz D, Nothnagel M, Schreiber S, Klein C, Hagenah J, Kasten M, Berg D, Srulijes K, Gasser T, Deuschl G, Kuhlenbaumer G (2010) LINGO1 is not associated with Parkinson’s disease in German patients. Am J Med Genet Part B Neuropsychiatr Genet 153b:1173–1178 Klebe S, Thier S, Lorenz D, Nothnagel M, Schreiber S, Klein C, Hagenah J, Kasten M, Berg D, Srulijes K, Gasser T, Deuschl G, Kuhlenbaumer G (2010) LINGO1 is not associated with Parkinson’s disease in German patients. Am J Med Genet Part B Neuropsychiatr Genet 153b:1173–1178
15.
Zurück zum Zitat Lang AE, Lozano AM (1998) Parkinson’s disease. First of two parts. N Eng J Med 339:1044–1053CrossRef Lang AE, Lozano AM (1998) Parkinson’s disease. First of two parts. N Eng J Med 339:1044–1053CrossRef
16.
Zurück zum Zitat Lettre G, Lange C, Hirschhorn JN (2007) Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 31:358–362CrossRefPubMed Lettre G, Lange C, Hirschhorn JN (2007) Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 31:358–362CrossRefPubMed
17.
Zurück zum Zitat Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed
18.
Zurück zum Zitat Llorens F, Gil V, Iraola S, Carim-Todd L, Marti E, Estivill X, Soriano E, del Rio JA, Sumoy L (2008) Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev Neurobiol 68:521–541CrossRefPubMed Llorens F, Gil V, Iraola S, Carim-Todd L, Marti E, Estivill X, Soriano E, del Rio JA, Sumoy L (2008) Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev Neurobiol 68:521–541CrossRefPubMed
19.
Zurück zum Zitat Lorenzo-Betancor O, Samaranch L, Garcia-Martin E, Cervantes S, Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P (2011) LINGO1 gene analysis in Parkinson’s disease phenotypes. Mov Disord 26:722–727CrossRefPubMed Lorenzo-Betancor O, Samaranch L, Garcia-Martin E, Cervantes S, Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P (2011) LINGO1 gene analysis in Parkinson’s disease phenotypes. Mov Disord 26:722–727CrossRefPubMed
20.
Zurück zum Zitat Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221–228CrossRefPubMed Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221–228CrossRefPubMed
21.
Zurück zum Zitat Mi S, Sandrock A, Miller RH (2008) LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol 40:1971–1978CrossRefPubMed Mi S, Sandrock A, Miller RH (2008) LINGO-1 and its role in CNS repair. Int J Biochem Cell Biol 40:1971–1978CrossRefPubMed
22.
Zurück zum Zitat Stefanova N, Bucke P, Duerr S, Wenning GK (2009) Multiple system atrophy: an update. Lancet Neurol 8:1172–1178CrossRefPubMed Stefanova N, Bucke P, Duerr S, Wenning GK (2009) Multiple system atrophy: an update. Lancet Neurol 8:1172–1178CrossRefPubMed
23.
Zurück zum Zitat Su FC, Chen CM, Chen YC, Wu YR (2012) LINGO-2 polymorphism and the risk of Parkinson’s disease in Taiwan. Parkinsonism Relat Disord 18:609–611CrossRefPubMed Su FC, Chen CM, Chen YC, Wu YR (2012) LINGO-2 polymorphism and the risk of Parkinson’s disease in Taiwan. Parkinsonism Relat Disord 18:609–611CrossRefPubMed
24.
Zurück zum Zitat Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ (2010) LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 16:109–111PubMedCentralCrossRefPubMed Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ (2010) LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 16:109–111PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ (2010) Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson’s disease in a Polish population, and a meta-analysis. Neurogenetics 11:401–408PubMedCentralCrossRefPubMed Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ (2010) Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson’s disease in a Polish population, and a meta-analysis. Neurogenetics 11:401–408PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ (2010) LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 11:401–408PubMedCentralCrossRefPubMed Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ (2010) LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 11:401–408PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103CrossRefPubMed Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103CrossRefPubMed
28.
Zurück zum Zitat Wu Y, Wang X, Xu W, Liu W, Fang F, Ding J, Song Y, Chen S (2012) Genetic variation in LINGO-1 (rs9652490) and risk of Parkinson’s disease: twelve studies and a meta-analysis. Neurosci Lett 522:67–72CrossRefPubMed Wu Y, Wang X, Xu W, Liu W, Fang F, Ding J, Song Y, Chen S (2012) Genetic variation in LINGO-1 (rs9652490) and risk of Parkinson’s disease: twelve studies and a meta-analysis. Neurosci Lett 522:67–72CrossRefPubMed
29.
Zurück zum Zitat Wu YR, Tan EK, Chen CM, Kumar PM, Lee-Chen GJ, Chen ST (2011) Genetic analysis of “leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1)” in two independent Chinese parkinson’s disease populations. Am J Med Genet Part B Neuropsychiatr Genet 156b:99–103CrossRef Wu YR, Tan EK, Chen CM, Kumar PM, Lee-Chen GJ, Chen ST (2011) Genetic analysis of “leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1)” in two independent Chinese parkinson’s disease populations. Am J Med Genet Part B Neuropsychiatr Genet 156b:99–103CrossRef
30.
Zurück zum Zitat Wu YW, Prakash KM, Rong TY, Li HH, Xiao Q, Tan LC, Au WL, Ding JQ, Chen SD, Tan EK (2011) Lingo2 variants associated with essential tremor and Parkinson’s disease. Hum Genet 129:611–615CrossRefPubMed Wu YW, Prakash KM, Rong TY, Li HH, Xiao Q, Tan LC, Au WL, Ding JQ, Chen SD, Tan EK (2011) Lingo2 variants associated with essential tremor and Parkinson’s disease. Hum Genet 129:611–615CrossRefPubMed
31.
Zurück zum Zitat Zuo X, Jiang H, Guo JF, Yu RH, Sun QY, Hu L, Wang L, Yao LY, Shen L, Pan Q, Yan XX, Xia K, Tang BS (2010) Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson’s disease in Chinese population. Neurosci Lett 481:69–72CrossRefPubMed Zuo X, Jiang H, Guo JF, Yu RH, Sun QY, Hu L, Wang L, Yao LY, Shen L, Pan Q, Yan XX, Xia K, Tang BS (2010) Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson’s disease in Chinese population. Neurosci Lett 481:69–72CrossRefPubMed
Metadaten
Titel
Analysis and meta-analysis of five polymorphisms of the LINGO1 and LINGO2 genes in Parkinson’s disease and multiple system atrophy in a Chinese population
verfasst von
YongPing Chen
Bei Cao
Jing Yang
QianQian Wei
Ru Wei Ou
Bi Zhao
Wei Song
XiaoYan Guo
HuiFang Shang
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7870-9

Weitere Artikel der Ausgabe 11/2015

Journal of Neurology 11/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.